scispace - formally typeset
C

Christina Wang

Researcher at Los Angeles Biomedical Research Institute

Publications -  450
Citations -  30621

Christina Wang is an academic researcher from Los Angeles Biomedical Research Institute. The author has contributed to research in topics: Testosterone (patch) & Sperm. The author has an hindex of 88, co-authored 422 publications receiving 27941 citations. Previous affiliations of Christina Wang include Queen Mary University of London & Cedars-Sinai Medical Center.

Papers
More filters
Journal ArticleDOI

The anti-progestin CDB 2914 has no antifertility effect in male rats

Christina Wang, +4 more
- 01 Mar 1995 - 
TL;DR: It is suggested that anti-progestins, when administered even at higher doses than those used in humans, have no contraceptive effect in adult male rats.
Journal ArticleDOI

Long‐term effects of megavoltage radiotherapy in acromegaly

Karen S.L. Lam, +4 more
- 01 Jun 1989 - 
TL;DR: With judicious selection of patients and use of adjunctive medical therapy, megavoltage radiotherapy remains a safe and satisfactory form of treatment for acromegaly especially if expert transphenoidal surgery is not readily available.
Journal ArticleDOI

The Response of Newborn Sheep to TRH with and without Somatostatin

Joseph Sack, +4 more
- 01 Jun 1977 - 
TL;DR: The results indicate that the hyperiodothyroninemia characteristic of the newborn period does not block the response to exogenous TRH, whereas the inhibitory effect of exogenous SRIF is observed in the newborn as in the adult.
Journal ArticleDOI

Levonorgestrel enhances spermatogenesis suppression by testosterone with greater alteration in testicular gene expression in men.

Yanhe Lue, +9 more
- 01 Mar 2009 - 
TL;DR: It is concluded that TU + LNG administration induces more changes in testicular gene expression than TU alone, and identified testicular-specific molecules that may serve as potential targets for male contraceptive development.
Journal ArticleDOI

Steady-state pharmacokinetics of oral testosterone undecanoate with concomitant inhibition of 5α-reductase by finasteride

Mara Y. Roth, +7 more
- 01 Dec 2011 - 
TL;DR: Serum testosterone and DHT were significantly increased into and above their normal ranges similarly by all three treatments, and co-administration of finasteride at 0.5 and 1.0 mg po twice daily had no significant effect on either serum testosterone or DHT.